Getting Mounjaro in Northern Ireland: what you need to know

Step 1 — understand what Mounjaro is and why it requires a prescriber

Tirzepatide, sold under the brand name Mounjaro, is a once-weekly injection made by Eli Lilly. It works by activating two gut-hormone receptors (GIP and GLP-1) which together reduce appetite, slow gastric emptying and help the body regulate blood sugar. It is the only dual-agonist weight-loss medicine licensed in the UK.

Because it is a Prescription-Only Medicine (POM), no pharmacy (online or physical) can supply it without a prescriber first assessing your health, medical history and current medicines. That is not a bureaucratic formality; it is the safeguard that makes the medicine appropriate for you. Clinical trial data published in the New England Journal of Medicine (SURMOUNT-1) showed an average body-weight reduction of around 20–21% over 72 weeks at the highest dose, but those results came from participants who were properly assessed and monitored throughout. The prescription step is part of what gets you those outcomes safely.

If you want a broader overview of the medicine before reading on, our Mounjaro treatment guide covers the full picture.

Step 2, check what the NHS currently offers in Northern Ireland

Health policy in Northern Ireland is devolved to the Department of Health NI, and while NICE guidance informs practice across the UK, implementation timelines can differ from England. The NHS rollout of tirzepatide for weight management in England is phased: from June 2025, patients with a BMI of 40 or above plus four or more qualifying conditions became eligible; a second cohort (BMI 35–39.9 with four conditions) was added from June 2026. Northern Ireland's equivalent rollout through HSC trusts is subject to local commissioning decisions, so the criteria and waiting times in Belfast differ from those in Manchester.

A question our prescribers hear most weeks from Northern Ireland patients is: "Will my GP prescribe it?" The honest answer is: it depends on your trust, your GP practice and the current local criteria. Some patients are already on NHS tirzepatide; many more are waiting. For those who do not meet the current NHS threshold or simply do not want to join a waiting list, private prescription is a straightforward alternative. The NHS England weight-management injections page sets out the national framework, which gives useful context even for Northern Ireland residents comparing what is available.

If you are curious about how the rollout plays out differently elsewhere in the UK, the picture in Scotland offers a useful comparison, and residents closer to the English border may also find it helpful to read about Mounjaro services in Northampton to see how access works in a nearby part of England.

Step 3, access Mounjaro through a regulated private pharmacy

For Northern Ireland residents, private prescription through a GPhC-registered online pharmacy is currently the most accessible legal route. The process at nume works like this: you complete a free clinical consultation online, which is personally reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician, reading your answers and making a clinical judgement. If treatment is appropriate, your prescription is issued and your medicine is dispatched the same day (for orders placed by 12pm, Monday to Friday), arriving free via tracked DPD delivery the next working day in plain, unbranded packaging.

There is no subscription and no auto-renewal. Before every repeat supply, your treatment is clinically re-reviewed. That matters for a medicine with a dose-escalation schedule: the prescriber confirms it is safe and appropriate to continue before anything is sent.

To verify any online pharmacy, check the GPhC register, nume's registration number is 9012878. If a seller cannot provide a register entry, that is a serious red flag. The MHRA has seized around 20 million doses of illegally traded weight-loss medicines worth approximately £45m, including counterfeit tirzepatide pens. Sellers offering these medicines without a prescription, via social media or at prices far below the market rate, are the clearest warning signs.

For context on what private treatment typically costs, our Mounjaro pricing page explains what a legitimate price includes and why the figures vary by dose and provider.

Step 4, know the eligibility criteria before you start

Clinical eligibility for private Mounjaro treatment follows the medicine's UK licence: adults aged 18 or over, with a BMI of 30 or above, or 27 or above if you have at least one weight-related condition. Conditions that typically qualify include hypertension, type 2 diabetes, dyslipidaemia and obstructive sleep apnoea. BMI alone is never the whole picture; the prescriber reviews your full health history, current medicines and any contraindications.

Tirzepatide is not recommended during pregnancy, breastfeeding or if you are trying to conceive. It is not licensed for anyone under 18. Certain conditions (including a personal or family history of medullary thyroid carcinoma or a syndrome called MEN2, and some gastrointestinal conditions) require specific discussion with a prescriber before any treatment begins. Women taking oral contraceptives should know that tirzepatide can reduce pill absorption in the early weeks of treatment; adding a non-oral method for the first four weeks and for four weeks after each dose increase is the standard precaution.

If you have already been assessed and are weighing up whether the medicine is right for you, our page on whether Mounjaro is worth it works through that question honestly. You can also read about the full Mounjaro injection process if you want to know what starting treatment actually feels like.

Ready to check your own eligibility? Start your free consultation and a prescriber will review your case the same day.